Related Experiment Video
Updated: Dec 2, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Limited Utility of Gadolinium Contrast Administration in Routine Multiple Sclerosis Surveillance
Gregory Johnston1, Thomas Johnson2, Andrew J Solomon3
1Larner College of Medicine at the University of Vermont, Burlington, VT.
Background And Purpose:
Assess the incidence of enhancing lesions on follow-up MRIs in patients with multiple sclerosis (MS) to determine the utility of intravenous, gadolinium-based contrast agent (IV-GBCA) use in routine follow-up imaging.
Methods:
We retrospectively identified head MRIs associated with an MS diagnosis acquired between January 1, 2015and January 10, 2018. Final reports were reviewed to determine the presence of (1) a new or larger lesion, (2) at least one enhancing lesion, and (3) if at least one enhancing lesion was new or larger on Fluid-Attenuation Inversion Recovery (FLAIR). For MRIs with at least one enhancing lesion, but no new or larger enhancing lesions, reports and images of the preceding MRI were reviewed.
Results:
A total of 1,805 MRIs performed on 920 patients were included. 354/1,805 (20%) MRIs reported new or enlarging lesions. 138/1,805 (8%) MRIs reported at least one enhancing lesion. Of these, 117/138 (85%) reported at least one enhancing lesion that was new or larger. In the remaining 21 MRIs which contained an enhancing lesion but none of the enhancing lesions were reported as new or enlarging, at least one enhancing lesion was present on preceding MRI.
Conclusions:
Enhancing lesions are uncommon on follow-up MRIs in MS patients. Our data suggest that new enhancing lesions are not present on a follow-up MRI when two conditions are met: (1) preceding MRI does not demonstrate any enhancing lesions and (2) there is no interval change of the lesions on the current 3D-T2-FLAIR sequence compared to the preceding 3D-T2-FLAIR sequence. IV-GBCA should be reserved for instances when temporal knowledge of lesion formation is needed.
Insights
Enhancing lesions on follow-up MRIs for multiple sclerosis (MS) are uncommon. Intravenous gadolinium-based contrast agents (IV-GBCA) are likely unnecessary for routine imaging unless assessing new lesion formation.
Area of Science:
- Neurology
- Radiology
- Medical Imaging
Background:
- Multiple sclerosis (MS) management relies on MRI surveillance.
- The utility of intravenous gadolinium-based contrast agents (IV-GBCA) in routine follow-up MRI for MS is debated.
- Assessing the incidence of enhancing lesions is crucial for optimizing imaging protocols.
Purpose of the Study:
- To evaluate the frequency of new or enlarging enhancing lesions in patients with MS on follow-up MRI.
- To determine the diagnostic yield of IV-GBCA in routine MS follow-up imaging.
- To inform guidelines on the appropriate use of contrast agents in MS monitoring.
Main Methods:
- Retrospective analysis of 1,805 head MRIs from 920 patients diagnosed with MS.
- Review of MRI reports for new/enlarging lesions and enhancing lesions.
- Comparison with preceding MRIs when enhancing lesions were present but not new/enlarging.
Main Results:
- 20% of MRIs showed new or enlarging lesions.
- Only 8% of MRIs reported at least one enhancing lesion.
- Of those with enhancing lesions, 85% were new or enlarging; the remainder showed pre-existing enhancing lesions.
Conclusions:
- Enhancing lesions are infrequent findings on routine follow-up MRIs in MS patients.
- New enhancing lesions are unlikely if prior MRIs were clear and current FLAIR sequences show no interval change.
- Reserve IV-GBCA for specific clinical scenarios requiring assessment of active lesion development.
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies III: Computed Tomography
Radiological Investigation I: X-ray and CT
Imaging Studies IV: Magnetic Resonance Imaging

